Probiotics may alleviate symptoms of hay fever, which may be related to bacteria in our gut and nose.

Published Date: 26 Apr 2023

The dreaded hay fever signs, including itchy eyes, sneezing, and a stuffy nose, have arrived for many people with the arrival of spring. Up to 42% of people experience hay fever, making it a widespread condition. Immune system overreaction is the cause of it.

Read Full News

Latest News

Which Drug Is Better for Remission in Ulcerative Colitis?

In patients with ulcerative colitis exposed to anti-TNF therapy, tofacitinib is linked to higher rates of clinical and steroid-free clinical remission than ustekinumab and vedolizumab.

Bone Pain in Paediatric IBD: A Rare but Important Link

In children with inflammatory bowel disease, persistent bone pain may signal chronic non-bacterial osteomyelitis, a rare association that commonly affects the lower limbs and pelvis.

Merck's Bowel Disease Drug Meets Main Goal in Late-stage Trial

Merck said on Monday its experimental drug met the main goal and key secondary goals ⁠in a late-stage trial in patients with a type of inflammatory bowel...

Common Anal Problems After Childbirth

Anal conditions affect up to 44% of women in labor yet remain underrecognized and poorly studied. Most cases improve with simple, conservative treatment.

China Approves CARsgen's CAR-T Treatment for Stomach Cancer

China's drug regulator said on Monday it has approved ⁠a CARsgen Therapeutics treatment for stomach cancer, a new milestone for CAR-T ⁠therapies, which engineer patients'...

Birth Factors Linked to Greater Early-Onset CRC Risk

Researchers conducted a population-based nested case-control study including individuals diagnosed with early-onset colorectal cancer and frequency-matched control individuals based on birth year.

Todays Updates

Induction Immunotherapy Has Durable Survival Benefit in LACC

Patients with locally advanced cervical cancer who receive dual checkpoint blockade before standard chemoradiation have high 3-year survival, but outcomes are poorer for those with ‘cold’ tumors.

Todays Updates

Induction Immunotherapy Has Durable Survival Benefit in LACC

Patients with locally advanced cervical cancer who receive dual checkpoint blockade before standard chemoradiation have high 3-year survival, but outcomes are poorer for those with ‘cold’ tumors.

Latest News

In patients with ulcerative colitis exposed to anti-TNF therapy, tofacitinib is linked to higher rates of clinical and steroid-free clinical remission than ustekinumab and vedolizumab.

In children with inflammatory bowel disease, persistent bone pain may signal chronic non-bacterial osteomyelitis, a rare association that commonly affects the lower limbs and pelvis.

Merck said on Monday its experimental drug met the main goal and key secondary goals ⁠in a late-stage trial in patients with a type of inflammatory bowel...

Anal conditions affect up to 44% of women in labor yet remain underrecognized and poorly studied. Most cases improve with simple, conservative treatment.

China's drug regulator said on Monday it has approved ⁠a CARsgen Therapeutics treatment for stomach cancer, a new milestone for CAR-T ⁠therapies, which engineer patients'...

Researchers conducted a population-based nested case-control study including individuals diagnosed with early-onset colorectal cancer and frequency-matched control individuals based on birth year.

News All Time

Simple Test May Cut Colonoscopy Frequency After Polypectomy

Testing fecal hemoglobin levels may help optimize colonoscopy resource allocation without compromising CRC risk reduction.

Immunotherapy Plus TACE Improves PFS in Unresectable HCC

The study adds to growing evidence that immunotherapy and chemoembolization prolong progression-free survival.

Flesh-eating Screwworm Confirmed in Texas Calf as Parasite Crosses Border From Mexico

New World screwworm, a parasitic fly that eats warm-blooded animals alive, has been found in a calf in Texas, the U.S. Department of Agriculture said on Wednesday evening,...

Iza-Bren Beats Chemo in Second-Line Esophageal Cancer

In a phase 3 trial, izalontamab brengitecan shows superiority to chemotherapy in previously treated esophageal squamous cell carcinoma, but questions remain about generalizability outside China.

Antibiotic Effects on the Gut Detected Up to 8 Years Later

Changes in gut microbiome diversity are observed with certain antibiotic drugs years later, even after just one course of therapy.

Natural Supplements Linked to Cases of Severe Liver Injury

Experts warn that concentrated herbal and dietary supplements are increasingly linked to severe liver injury, while regulation remains limited.

Remote Monitoring in Cirrhosis Could Reduce Admissions

A digital monitoring system for advanced cirrhosis may help detect deterioration earlier and reduce hospital admissions.

Blood Test Added to US Colorectal Cancer Screening Options

People who skip colorectal cancer screening because colonoscopy or stool testing seems too burdensome now have a blood test option from Guardant Health among recommendations...

Can Intraperitoneal Paclitaxel Improve OS in Gastric Cancer?

A phase 3 trial explores whether adding intraperitoneal paclitaxel to intravenous paclitaxel plus S-1 improves overall survival in patients with gastric cancer and peritoneal metastasis.

Pancreatic Cancer Testing Falls Short of Goals

Researchers conducted a cross-sectional electronic survey to see whether respondents were offered and completed germline genetic testing following a pancreatic ductal adenocarcinoma diagnosis.

Pancreatic Cysts: What’s the Actual Cancer Risk?

Pancreatic cysts are common and usually considered low risk — but even those lesions signal a significantly elevated and sustained cancer risk.

UTI Treatment Shift: Is Nitrofurantoin Coming Out on Top?

A large Spanish trial reports higher cure rates with 5-day nitrofurantoin therapy than with fosfomycin or pivmecillinam in women with uncomplicated UTIs.

Takeda Engaged in Antitrust Scheme to Delay Generic Constipation Drug, US Jury Finds

A U.S. jury on Monday found Takeda Pharmaceutical liable for causing about $885 million in damages by delaying a generic version of its constipation drug Amitiza through an...

Blood Proteins Link Poor Sleep to Increased Cancer Risk

Suboptimal sleep health, reflected in low sleep proteomic scores, is consistently associated with an increased risk for cancer, particularly gastrointestinal malignancies.

Housing Instability Tied to Lower Rates of CRC Screening

Unmet health-related social needs, especially housing instability and transportation barriers, are linked to lower rates of screening for colorectal cancer among US adults.

Olanzapine Cuts Radiation-Induced Nausea

The drug, widely used for chemotherapy-related nausea, may also be highly effective for symptoms caused by abdominal-pelvic radiotherapy.

Recommended News For You

ctDNA Predicts Relapse in Locally Advanced Cervical Cancer

Bladder cancer link to explosive ordnance exposure among Army veteran bomb disposal officers

Study offers clearer picture of childhood brain tumor survival

Adding Lenvatinib to Pembro Ups PFS in Head and Neck Cancer

How access to specialized cancer centers affects glioblastoma outcomes

Triplet Therapy Improves Posttransplant Outcomes in Myeloma

Does pollution cause cancer?

Recommended Articles For You

Case Study: Artificial Intelligence in Early Cancer Detection 

Understanding Hemosiderosis: Causes, Symptoms, and Treatment Options 

Oncology Drug Trends 2025: FDA Approvals, Immuno-Oncology, and Clinical Trial Insights 

Beta-2 Microglobulin: Function, Role in Disease & Clinical Significance Explained 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Can Concurrent Boost Safely Shorten Breast Cancer Radiation?

2.

Q&A: Why adolescents and young adults with cancer are falling behind

3.

PRO Data Strengthen Case for Dato-DXd in First-Line TNBC

4.

Potentially Novel Approach for Treating Advanced Colorectal Cancer with KRAS Mutations.

5.

Ketamine plus psychotherapy for "excellent" PTSD

1.

Pembrolizumab Plus Lenvatinib in EBV-Associated Advanced Intrahepatic Cholangiocarcinoma: Case Study

2.

The Ultimate Guide to Understanding Abiraterone and its Uses in Cancer Treatment 

3.

Therapeutic Innovations Through Germline Predisposition in Acute Leukemias and Myeloid Neoplasms

4.

Unlocking the Secret to Accurate ANC Calculation with This Informative Blog Post

5.

Beyond the Standard: Personalized Cancer Vaccines and the Dawn of a New Era in Pediatric Oncology

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology

5.

International Lung Cancer Congress®

1.

Navigating the Complexities of Ph Negative ALL - Part XII

2.

Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)

3.

Nimotozumab Plus Chemo-radiotherapy v/s Placebo Plus Chemo-radiotherapy in Locally Advanced Nasopharyngeal Carcinoma

4.

Recent Data Analysis for First-Line Treatment of ALK+ NSCLC

5.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VI

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot